The U.S. Department of Agriculture’s National Agricultural Statistics Service (NASS) plans to send 20,500 hemp producers across the country their first Hemp Acreage and Production Survey, beginning October 18.
Articles
PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome
PharmaTher receives its second FDA orphan drug designation for a ketamine-based therapy.
MindMed Joins Clinical Trials Transformation Initiative
MindMed joins the Clinical Trials Transformation Initiative, a forward-looking healthcare association that develops/promotes new health therapies.
Novamind Granted DEA Licenses for Psilocybin Research
Novamind's new DEA licenses open up opportunities to host formal clinical trials.
Denver City Panel Pushes To Expand Psilocybin Decriminalization With Gifting And Communal Use
Denver activists, police officials and other experts have agreed upon a set of recommendations to expand the city’s historic vote to decriminalize psilocybin in 2019—including by deprioritizing criminal enforcement against additional activities like gifting and communal use of the fungi.
Cybin Files an International Patent Application Covering Psychedelic Delivery Methods
Cybin files a new patent application in support of the development of drug candidate CYB004.
Republican Ohio Lawmakers Announce Marijuana Legalization Bill, Reflecting Recent Bipartisan Shift On Issue
For years, Democratic lawmakers have mostly led the charge in pushing for marijuana legalization—but that seems to be changing of late.
First Nevada Cannabis Dispensary Approved at Border of Idaho
The Nevada-Idaho border is about to get a little bit greener.
Psychedelic Stocks: Financial Strength, Growth Potential, Compelling Valuations
Psychedelic stocks today are cash-rich with extremely attractive valuations. Blue-chip stocks sit with record debt levels and grossly inflated valuations. Advantage: psychedelic stocks.
U.S. Senators Ask Justice Department to Decriminalize Cannabis
U.S. Senators Cory Booker and Elizabeth Warren have sent a letter to Attorney General Merrick Garland urging the Department of Justice to decriminalize cannabis by removing it from the federal controlled substances list.
Oregon State University Hemp Center Receives $10M Grant
The Global Hemp Innovation Center at Oregon State University announced last week that it has received a $10 million grant from the U.S. Department of Agriculture to study and define the economic opportunities for hemp in the western United States.
GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders
A coalition of Pennsylvania lawmakers introduced a bill this week that’s meant to promote research into the therapeutic potential of psilocybin mushrooms for mental health conditions such as post-traumatic stress disorder —the latest example of how the psychedelics reform movement is gaining momentum.
Oklahoma Advocates Campaign to Put Cannabis Reforms on 2022 Ballots
Cannabis advocates in Oklahoma have filed ballot initiatives for 2022 to legalize adult-use cannabis and replace the current medical cannabis oversight agency, the Tulsa World reports.
Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities
Numinus announces expansion of its psychedelics research facility and an application to Health Canada for a second Dealer's License.
NBA Will Not Randomly Test Players for Cannabis During 2021-22 Season
The National Basketball Association has agreed to not randomly test players for cannabis during the upcoming season, continuing the policy which started during the “restart bubble” and was continued last season, the Associated Press reports.